{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-032512","form_type":"8-K","ticker":"STAA","cik":"0000718937","company_name":"STAAR SURGICAL CO","filed_at":"2024-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.742423+00:00","generated_at":"2026-06-04T16:11:03.865413+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"STAAR Surgical surpasses 3 million cumulative ICL sales globally","bullets":["More than 3 million Implantable Collamer Lenses (ICLs) sold worldwide; EVO ICL accounts for ~2.5 million of that total.","CEO Tom Frinzi cites EVO ICL as next logical step in refractive innovation with clear patient outcome differentiators.","Milestone reflects growing adoption for myopia, astigmatism, and presbyopia correction via minimally invasive procedure."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-032512","json":"https://secwatch.observer/filing/0000950170-24-032512.json","markdown":"https://secwatch.observer/filing/0000950170-24-032512.md","text":"https://secwatch.observer/filing/0000950170-24-032512.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/718937/000095017024032512/0000950170-24-032512-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/718937/000095017024032512/staa-20240318.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T16:11:03.865413+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}